US BANCORP \DE\ - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$127,109
-50.3%
5,672
-9.7%
0.00%
Q2 2023$255,530
-37.2%
6,283
-25.3%
0.00%
-100.0%
Q1 2023$407,187
+37.7%
8,406
+8.5%
0.00%0.0%
Q4 2022$295,665
-28.9%
7,746
-6.5%
0.00%0.0%
Q3 2022$416,000
+15.9%
8,285
-7.4%
0.00%0.0%
Q2 2022$359,000
+4.1%
8,946
-3.4%
0.00%0.0%
Q1 2022$345,000
+2.7%
9,257
+9.9%
0.00%0.0%
Q4 2021$336,000
+25.4%
8,425
+16.9%
0.00%0.0%
Q3 2021$268,000
-4.6%
7,206
+8.2%
0.00%0.0%
Q2 2021$281,000
-2.4%
6,657
+9.7%
0.00%0.0%
Q1 2021$288,000
+1500.0%
6,069
+1909.6%
0.00%
Q4 2020$18,000
+350.0%
302
+251.2%
0.00%
Q3 2020$4,000
+300.0%
86
+207.1%
0.00%
Q2 2020$1,000
-98.8%
28
-98.5%
0.00%
Q2 2019$86,000
-26.5%
1,908
-38.7%
0.00%
Q1 2019$117,000
+19.4%
3,115
+9.3%
0.00%
Q4 2018$98,000
+10.1%
2,851
+50.6%
0.00%
Q3 2018$89,000
+53.4%
1,893
+9.2%
0.00%
Q2 2018$58,0001,733
+24657.1%
0.00%
Q1 2016$0
-100.0%
7
-99.0%
0.00%
Q3 2015$18,0006960.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders